Everolimus mitigates the risk of hepatocellular carcinoma recurrence after liver transplantation

被引：0
|
作者：
De Simone, Paolo [1 ]
Precisi, Arianna [2 ]
Lai, Quirino [2 ]
Ducci, Juri [2 ]
Campani, Daniela [1 ]
Marchetti, Piero [1 ]
Gitto, Stefano [3 ]
机构：
[1] Univ Pisa, Pisa, Italy
[2] Azienda Ospeda Univ Pisana, Pisa, Italy
[3] Univ Florence, Florence, Italy
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-502
引用
收藏
页码：S456 / S456
页数：1
相关论文
共 50 条
  • [1] Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation
    De Simone, Paolo
    Precisi, Arianna
    Lai, Quirino
    Ducci, Juri
    Campani, Daniela
    Marchetti, Piero
    Gitto, Stefano
    CANCERS, 2024, 16 (07)
  • [2] Effect of everolimus on hepatocellular carcinoma recurrence after liver transplantation
    Joo, D. J.
    Lee, J. J.
    Kim, D. G.
    Lee, J. G.
    Lee, J.
    Kim, S. H.
    Han, D. H.
    Lee, H. S.
    Ju, M. K.
    Choi, G. H.
    Choi, J. S.
    Kim, M. S.
    Kim, S., I
    TRANSPLANTATION, 2019, 103 (08) : 54 - 55
  • [3] EVEROLIMUS AND SORAFENIB FOR RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION
    De Simone, Paolo
    Pezzati, Daniele
    Lai, Quirino
    Ghinolfi, Davide
    Coletti, Laura
    Precisi, Arianna
    Leonardi, Giulia
    Carrai, Paola
    Filipponi, Franco
    TRANSPLANT INTERNATIONAL, 2013, 26 : 293 - 293
  • [4] Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
    Rodriguez-Peralvarez, Manuel
    Guerrero, Marta
    Barrera, Lydia
    Ferrin, Gustavo
    Alamo, Jose M.
    Ayllon, Maria D.
    Suarez Artacho, Gonzalo
    Montero, Jose L.
    Briceno, Javier
    Bernal, Carmen
    Padillo, Javier
    Marin-Gomez, Luis M.
    Pascasio, Juan M.
    Poyato, Antonio
    Gomez-Bravo, Miguel A.
    De la Mata, Manuel
    TRANSPLANTATION, 2018, 102 (12) : 2056 - 2064
  • [5] Everolimus plus Sorafenib as a treatment option for hepatocellular carcinoma recurrence after liver transplantation
    Saliba, Faouzi
    Nitta, Hidetoshi
    Younes, Aline
    Karam, Vincent H.
    Sobesky, Rodolphe
    Vibert, Eric
    Coilly, Audrey
    Antonini, Theresa
    Cherqui, Daniel
    Adam, Rene
    Samuel, Didier
    HEPATOLOGY, 2017, 66 : 901A - 902A
  • [6] Trough Levels of Everolimus Are Associated With Recurrence Rates of Hepatocellular Carcinoma After Liver Transplantation
    Cholongitas, E.
    Antoniadis, N.
    Goulis, I.
    Theocharidou, E.
    Imvrios, G.
    Giouleme, O.
    Filis, D.
    Mouloudi, E.
    Akriviadis, E.
    Fouzas, I.
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (02) : 450 - 453
  • [7] EVEROLIMUS PLUS SORAFENIB AS A TREATMENT OPTION FOR HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
    Saliba, F.
    Younes, A.
    Nitta, H.
    Karam, V.
    Sobesky, R.
    Vibert, E.
    Coilly, A.
    Antonini, T.
    Cherqui, D.
    Baba, H.
    Adam, R.
    Samuel, D.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 17 - 17
  • [8] Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Recurrence Characteristics and Risk Factors
    Li, Chuan
    Wen, Tian-Fu
    Liao, Zhi-Xue
    Yan, Lv-Nan
    Li, Bo
    Zeng, Yong
    Wang, Wen-Tiao
    Xu, Ming-Qing
    Yang, Jia-Ying
    Wei, Yong-Gang
    HEPATO-GASTROENTEROLOGY, 2010, 57 (99-100) : 567 - 570
  • [9] Hepatocellular Carcinoma Recurrence After Liver Transplantation
    Gabutti, Alejandro
    Bhoori, Sherrie
    Cascella, Tommaso
    Bongini, Marco
    ONCOLOGY-NEW YORK, 2020, 34 (03): : 91 - 94
  • [10] Recurrence of hepatocellular carcinoma after liver transplantation
    Escartin, A.
    Sapisochin, G.
    Bilbao, I.
    Vilallonga, R.
    Bueno, J.
    Castells, L.
    Dopazo, C.
    Castro, E.
    Caralt, M.
    Balsells, J.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2308 - 2310
12345